Establishing a pediatric reference interval for plasma calprotectin

References

• Lundgren D, Widbom L, Hultdin J, et al. Preclinical markers in inflammatory bowel disease. A nested case-control study. Crohns Colitis 360. 2021;3:1–7.
   Google Scholar
• Udegbune M, Sharrod-Cole H, Townsend S, et al. Diagnostic performance of serum calprotectin in discriminating active from inactive ulcerative colitis in an outpatient setting. Ann Clin Biochem. 2022;59(6):404–409. doi: 10.1177/00045632221116830.
   PubMed Web of Science ®Google Scholar
• Boschetti G, Laidet M, Moussata D, et al. Levels of fecal calprotectin are associated with the severity of postoperative endoscopic recurrence in asymptomatic patients with Crohn’s disease. Am J Gastroenterol. 2015;110(6):865–872. doi: 10.1038/ajg.2015.30.
   PubMed Web of Science ®Google Scholar
• Boschetti G, Garnero P, Moussata D, et al. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn’s disease. Inflamm Bowel Dis. 2015;21(2):331–336. doi: 10.1097/MIB.0000000000000273.
   PubMed Web of Science ®Google Scholar
• Carlsen K, Malham M, Hansen LF, et al. Serum calprotectin in adolescents with inflammatory bowel disease—a pilot investigation. J Pediatr Gastroenterol Nutr. 2019;68(5):669–675. doi: 10.1097/MPG.0000000000002244.
   PubMed Web of Science ®Google Scholar
• Kalla R, Kennedy NA, Ventham NT, et al. Serum calprotectin: a novel diagnostic and prognostic marker in inflammatory bowel diseases. Am J Gastroenterol. 2016;111(12):1796–1805. doi: 10.1038/ajg.2016.342.
   PubMed Web of Science ®Google Scholar
• Mori A, Mitsuyama K, Sakemi R, et al. Evaluation of serum calprotectin levels in patients with inflammatory bowel disease. Kurume Med J. 2021;66(4):209–215. doi: 10.2739/kurumemedj.MS664009.
   PubMedGoogle Scholar
• Yasuda R, Arai K, Kudo T, et al. Serum leucine-rich alpha-2 glycoprotein and calprotectin in children with inflammatory bowel disease: a multicenter study in Japan. J Gastroenterol Hepatol. 2023;38(7):1131–1139. doi: 10.1111/jgh.16166.
   PubMed Web of Science ®Google Scholar
• Meuwis MA, Vernier-Massouille G, Grimaud JC, et al. Serum calprotectin as a biomarker for Crohn’s disease. J Crohns Colitis. 2013;7(12):678–683.
   PubMedGoogle Scholar
• Wang S, Song R, Wang Z, et al. S100A8/A9 in inflammation. Front Immunol. 2018;9:1298. doi: 10.3389/fimmu.2018.01298.
   PubMed Web of Science ®Google Scholar
• Mylemans M, Nevejan L, Van Den Bremt S, et al. Circulating calprotectin as biomarker in neutrophil-related inflammation: pre-analytical recommendations and reference values according to sample type. Clin Chim Acta. 2021;517:149–155. doi: 10.1016/j.cca.2021.02.022.
   PubMed Web of Science ®Google Scholar
• Nevejan L, Mylemans M, Vander Cruyssen B, et al. Pre-analytical recommendations and reference values for circulating calprotectin are sample type and assay dependent. Clin Chem Lab Med. 2022;60(2):57–60.
   Web of Science ®Google Scholar
• Blavnsfeldt AG, Parkner T, Knudsen CS. Plasma calprotectin – preanalytical stability and interference from hemolysis. Scand J Clin Lab Invest. 2022;82(5):349–355. doi: 10.1080/00365513.2022.2092901.
   PubMed Web of Science ®Google Scholar
• Nordal HH, Fagerhol MK, Halse AK, et al. Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis. Scand J Clin Lab Invest. 2018;78(1–2):102–108. doi: 10.1080/00365513.2017.1419371.
   PubMed Web of Science ®Google Scholar
• Malham M, Carlsen K, Riis L, et al. Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative colitis. Scand J Gastroenterol. 2019;54(10):1214–1219. doi: 10.1080/00365521.2019.1665097.
   PubMed Web of Science ®Google Scholar
• Horowitz G. Defining, establishing, and verifying reference intervals in the clinical laboratory; approves guideline. 3rd ed. Clinical and Laboratory Standards Institute (CLSI document EP28-A3c): Wayne, PA; 2008.
   Google Scholar
• Lahti A, Petersen PH, Boyd JC, et al. Partitioning of nongaussian-distributed biochemical reference data into subgroups. Clin Chem. 2004;50(5):891–900. doi: 10.1373/clinchem.2003.027953.
   PubMed Web of Science ®Google Scholar
• Colantonio DA, Kyriakopoulou L, Chan MK, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 2012;58(5):854–868. doi: 10.1373/clinchem.2011.177741.
   PubMed Web of Science ®Google Scholar
• Schlenz H, Intemann T, Wolters M, et al. C-reactive protein reference percentiles among pre-adolescent children in Europe based on the IDEFICS study population. Int J Obes. 2014;38(S2):S26–S31. doi: 10.1038/ijo.2014.132.
   Google Scholar
• Simundic AM, Baird G, Cadamuro J, et al. Managing hemolyzed samples in clinical laboratories. Crit Rev Clin Lab Sci. 2020;57(1):1–21. doi: 10.1080/10408363.2019.1664391.
   PubMed Web of Science ®Google Scholar